Rheumatoid arthritis CD8+ T Cells
About:Human CD8+ T Cells are isolated from peripheral blood of IRB-consented donors diagnosed with rheumatoid arthritis. Ideal for investigations of inflammatory immune activation and cytotoxic T cell–mediated autoimmune mechanisms.
About Rheumatoid arthritis CD8+ T Cells
Rheumatoid Arthritis CD8+ T Cells
CD8+ T Cells for Inflammatory and Autoimmune Research
Human CD8+ T Cells are isolated from peripheral blood of IRB-consented donors diagnosed with rheumatoid arthritis. CD8+ cytotoxic lymphocytes contribute to chronic synovial inflammation and immune-mediated joint damage. These cells are suitable for studies investigating inflammatory signaling, immune activation pathways, and development of targeted immunotherapies.
Product Features
- Research Use Only (RUO), CD8 positive T cells
- Isolated from clinically confirmed rheumatoid arthritis donors
- High purity and viability (≥90% CD8+ cells)
- Cryopreserved in CryoStor® CS10 media
- Processed within 24 hours of collection
- IRB-approved protocols with electronic informed consent
Donor Metadata
- Confirmed diagnosis and clinical history
- Demographic data: age, sex assigned at birth, race/ethnicity
- Medication and treatment background when available
Applications
- Inflammatory cytokine profiling
- Cytotoxic signaling studies
- Immunotherapy evaluation
- Functional immune assays
- Transcriptomic analysis
Compliance and Quality Assurance
- IRB-approved collections and standardized procedures
- 21 CFR Part 11–compliant e-consent system
- HIPAA-compliant data management
Ordering & Customization
Human CD8+ T Cells are available in customizable aliquot sizes. For international orders or documentation needs, please contact learnmore@sanguinebio.com to confirm requirements and availability.
Donor Metadata
- Verified diagnosis and clinical history
- Demographic data: age, sex assigned at birth, race/ethnicity
- Medication and treatment background when available
Compliance and Quality Assurance
- IRB-approved collections and standardized procedures
- 21 CFR Part 11-compliant e-consent system
- HIPAA-compliant data management
Ordering & Customization
Human CD8+ T Cells are available in customizable aliquot sizes. For international orders or documentation needs, please contact learnmore@sanguinebio.com to confirm requirements and availability. We also work with multiple ordering platforms and distributors, learn more here.
Where can I find your complete catalog?
You can find our full product catalog here.
How long can samples be stored?
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
What customization options are available?
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
Do you offer prospective collections?
Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.
What is the turnaround time for custom collections?
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
Do you have samples in stock?
YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
What does unique donor mean?
Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
Are samples collected under IRB-approved protocols?
YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Frequently Asked Questions
Ask a Question
Pair with a Healthy Control
Match your Rheumatoid arthritis CD8+ T Cells with normal donor samples for comparison
Healthy CD8+ T Cells
3 In Stock View InventoryNeed a custom CD8+ T Cells cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.